ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
3P and Buzzard Pharmaceuticals Enter Cancer Collaboration contractpharma
May 08, 2021?3P Biopharmaceuticals (3P) and Buzzard Pharmaceuticals (Buzzard) have entered into a partnership agreement for manufacturing of the potent IL-I inhibitor Isunakinra, a recombinant protein for cancer indications.
Pharma Sources Insight January 2025
